List of works - Martine Guillermier

A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin

scientific article published on 29 May 2013

Activation of astrocytes by CNTF induces metabolic plasticity and increases resistance to metabolic insults.

scientific article

B(0) homogeneity throughout the monkey brain is strongly improved in the sphinx position as compared to the supine position.

scientific article published in March 2006

Capucin does not modify the toxicity of a mutant Huntingtin fragment in vivo

scientific article published on 24 February 2012

Complex roles for reactive astrocytes in the triple transgenic mouse model of Alzheimer disease

scientific article published on 18 February 2020

Correction: IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates

scientific article (publication date: 30 January 2013)

Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase

scientific article

Diffusion-weighted NMR spectroscopy allows probing of 13C labeling of glutamate inside distinct metabolic compartments in the brain.

scientific article published in August 2008

IRC-082451, a novel multitargeting molecule, reduces L-DOPA-induced dyskinesias in MPTP Parkinsonian primates

scientific article

In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects

scientific article

Intracellular metabolites in the primate brain are primarily localized in long fibers rather than in cell bodies, as shown by diffusion-weighted magnetic resonance spectroscopy.

scientific article

Isoflurane strongly affects the diffusion of intracellular metabolites, as shown by 1H nuclear magnetic resonance spectroscopy of the monkey brain.

scientific article published on 21 June 2006

Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease

scientific article

Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease

scientific article published on 16 October 2018

Multimodal neuroimaging provides a highly consistent picture of energy metabolism, validating 31P MRS for measuring brain ATP synthesis

scholarly article

Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging.

scientific article published in August 2012

Restricted transgene expression in the brain with cell-type specific neuronal promoters

scientific article

Restricted transgene expression in the brain with cell-type specific neuronal promoters

Striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo

scientific article

The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivo

scientific article published on 09 October 2019

The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer's and Huntington's diseases.

scientific article published on February 2015

The neuroprotective agent CNTF decreases neuronal metabolites in the rat striatum: an in vivo multimodal magnetic resonance imaging study

scientific article

The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin.

scientific article published on 9 March 2018

List of works by Martine Guillermier

A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin

Activation of astrocytes by CNTF induces metabolic plasticity and increases resistance to metabolic insults.

B(0) homogeneity throughout the monkey brain is strongly improved in the sphinx position as compared to the supine position.

Capucin does not modify the toxicity of a mutant Huntingtin fragment in vivo

Complex roles for reactive astrocytes in the triple transgenic mouse model of Alzheimer disease

Correction: IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates

Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase

Diffusion-weighted NMR spectroscopy allows probing of 13C labeling of glutamate inside distinct metabolic compartments in the brain.

IRC-082451, a novel multitargeting molecule, reduces L-DOPA-induced dyskinesias in MPTP Parkinsonian primates

In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects

Intracellular metabolites in the primate brain are primarily localized in long fibers rather than in cell bodies, as shown by diffusion-weighted magnetic resonance spectroscopy.

Isoflurane strongly affects the diffusion of intracellular metabolites, as shown by 1H nuclear magnetic resonance spectroscopy of the monkey brain.

Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease

Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease

Multimodal neuroimaging provides a highly consistent picture of energy metabolism, validating 31P MRS for measuring brain ATP synthesis

Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging.

Restricted transgene expression in the brain with cell-type specific neuronal promoters

Restricted transgene expression in the brain with cell-type specific neuronal promoters

Striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo

The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivo

The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer's and Huntington's diseases.

The neuroprotective agent CNTF decreases neuronal metabolites in the rat striatum: an in vivo multimodal magnetic resonance imaging study

The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin.